Shares in Synthes, the Swiss surgical products and medical services group, rose as it confirmed that it was in talks with Johnson & Johnson of the US Source: FT.com - Pharmaceuticals
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in ourCookies used here:Privacy / Disclaimer,